Login / Signup
Sven Blomme
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Clinical Trial
Phase Iii
Quantum Dots
Pluripotent Stem Cells
Top Venues
Diabetologia
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Chantal Mathieu
,
Alice E Wiedeman
,
Karen Cerosaletti
,
Sarah Alice Long
,
Elisavet Serti
,
Laura G Cooney
,
Joan Vermeiren
,
Silvia Caluwaerts
,
Karolien Van Huynegem
,
Lothar Steidler
,
Sven Blomme
,
Pieter Rottiers
,
Gerald T Nepom
,
Kevan C Herold
,
null null
A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab.
Diabetologia
(2023)